How AI Found a New Pancreatic Cancer Drug
Mayo Clinic and Sravathi AI have developed a potential GIPC1 inhibitor for pancreatic cancer. Know how AI identified the treatment and its human-use timeline.
Mayo Clinic and Sravathi AI have developed a potential GIPC1 inhibitor for pancreatic cancer. Know how AI identified the treatment and its human-use timeline.